Improving the Efficiency of Gene Targeting Using TAL Effector Nucleases
Improving the Efficiency of Gene Targeting Using TAL Effector Nucleases
批准号:
8609491
负责人:
Shengdar Tsai
金额:
$5.51万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2015-01-31
关键词:
AIDS/HIV problemAchievementAddressBase PairingBiological ModelsCell LineCellsChemokine (C-C Motif) Receptor 5ClinicalDNADNA Double Strand BreakDNA SequenceDevelopmentDiseaseDisease modelDouble Strand Break RepairEngineeringEnzymesEpitopesEventFoundationsFrequenciesGene MutationGene TargetingGenesGeneticGenetic EngineeringGenomeGenome engineeringGoalsHIVHumanHuman Cell LineHuman GeneticsHuman GenomeInvestigationJournalsLibrariesMediatingMethodsModificationMutationNamesNatureNonhomologous DNA End JoiningNucleotidesOligonucleotidesOrganismPathway interactionsPharmaceutical PreparationsPhase I Clinical TrialsPlasmidsPluripotent Stem CellsPoint MutationProcessResearchRiskSingle Nucleotide PolymorphismSingle-Stranded DNASiteTechnologyTestingTherapeuticTranscription CoactivatorVariantWorkZinc Fingersbasebiological researchcareercell typeclinically relevantcombinatorialdesigngenetic manipulationgenetic varianthomologous recombinationhuman diseaseimprovedinduced pluripotent stem cellinhibitor/antagonistinterestmouse modelnucleasepost-doctoral trainingpublic health relevancerepairedsmall moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to develop broadly applicable methods to utilize engineered nucleases to facilitate gene targeting in human somatic and pluripotent cells. The specific aims are: 1) to enhance our ability to genetically engineer all types of genetic modifications by homologous recombination using engineered nucleases (TAL effector nucleases or TALENs) in human somatic and pluripotent cells and 2) to improve our ability to use TALEN-derived nicking enzymes for homologous recombination. This proposal will leverage a high-throughput assembly method for creating engineered TALENs and apply it to the genetic engineering of human cell lines. Successful development of the proposed methods for introducing small insertions and single-base modifications to the human genome will enhance the ability to systematically investigate the relationship between human gene variation and function and enable genetic manipulations that have been previously limited to mouse model systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sensitive, unbiased, high-throughput, cellular GUIDE-seq-2 genome-wide activity assay for therapeutic genome editing INDs
-
批准号:10668823
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2023
-
负责人:Shengdar Tsai
-
依托单位:
Ultra-sensitive, unbiased, high-throughput, biochemical CHANGE-seq genome-wide activity and gRNA sequencing assays for therapeutic genome editing INDs
-
批准号:10668824
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2023
-
负责人:Shengdar Tsai
-
依托单位:
A novel human T-cell platform to define biological effects of genome editing
-
批准号:10016298
-
项目类别:
-
资助金额:$61.07万
-
财政年份:2018
-
负责人:Shengdar Tsai
-
依托单位:
A novel human T-cell platform to define biological effects of genome editing
-
批准号:10202452
-
项目类别:
-
资助金额:$61.01万
-
财政年份:2018
-
负责人:Shengdar Tsai
-
依托单位:
A novel human T-cell platform to define biological effects of genome editing
-
批准号:10434027
-
项目类别:
-
资助金额:$61.0万
-
财政年份:2018
-
负责人:Shengdar Tsai
-
依托单位:
Improving the Efficiency of Gene Targeting Using TAL Effector Nucleases
-
批准号:8456449
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2013
-
负责人:Shengdar Tsai
-
依托单位:
海外基金